HF
EFTRW

HRT Financial’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

HRT Financial’s Portfolio EFTRW Stock Details EFTRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,209
Closed -$4K – 3684
2022
Q2 		$4K Sell
20,209
-4,082
-17% -$1.11K ﹤0.01% 2761
2022
Q1 		$10K Hold
24,291
– – ﹤0.01% 2901
2021
Q4 		$21K Sell
24,291
-11,379
-32% -$14.3K ﹤0.01% 2948
2021
Q3 		$58K Buy
+35,670
New +$43.3K ﹤0.01% 3020

Other funds holding EFTRW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
ECM
Evolution Capital Management Crystal Bay, Nevada $29M AUM 2.56% 1-Year Est. Return
ICM
III Capital Management Boca Raton, Florida $344M AUM 11.22% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

HRT Financial's EFTRW Position: Q3 2022 in Review

HRT Financial sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q3 2022, closing a stake of 20,209 shares — an estimated $4K sold.

HRT Financial first reported a position in EFTRW in Q3 2021 and held it in 4 quarters. The position peaked at $58K in Q3 2021. 12 funds tracked by Wall St. Rank hold EFTRW as of Q3 2022.

  • HRT Financial reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 20,209 eFFECTOR Therapeutics, Inc. Warrant shares in Q3 2022, an estimated $4K.
  • HRT Financial first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q3 2021 and held it in 4 quarters.
  • HRT Financial's eFFECTOR Therapeutics, Inc. Warrant position peaked at $58K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.